MNTA Financial Facts
General and administrative: 9.72MInterest income: 269K
See Full Income Statement
Prepaid expenses and other current assets: 3.64M
Total liabilities: 42.64M
See Full Balance Sheet
Earnings History for Momenta Pharmaceuticals Inc (MNTA)
|
Expand Research on MNTA
| Next EPS Date | 8/1/13 *Est. | EPS Growth Rate | -380.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -24.2% | Revenue Growth Rate | -68.6% *Last Qtr. |
| Average % Move 1-Wk after EPS | -6.3% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4/30/13 |
Q113 | -$0.48 | -$0.43 | -$0.05 | $7.6M | $10.28M | N/A / N/A | N/A | +3.8% | Details | |
| 2/15/13 |
Q412 | -$0.35 | -$0.41 | +$0.06 | $12.7M | $10.41M | N/A / N/A | N/A | +9% | Details | |
| 11/7/12 |
Q312 | -$0.51 | -$0.27 | -$0.24 | $5.1M | $16.48M | N/A / N/A | N/A | +0.7% | Details | |
| 8/2/12 |
Q212 | -$0.20 | -$0.18 | -$0.02 | $21.9M | $18.99M | N/A / N/A | N/A | -4.7% | Details | |
| 5/3/12 |
Q112 | -$0.10 | $0.21 | -$0.31 | $24.2M | $37.38M | N/A / N/A | N/A | -16.3% | Details | |
| 2/9/12 |
Q411 | $0.20 | $0.27 | -$0.07 | $29.5M | $38.59M | N/A / N/A | N/A | -17.8% | Details | |
| 11/7/11 |
Q311 | $1.18 | $1.30 | -$0.12 | $87.9M | $90.92M | N/A / N/A | N/A | -9.5% | Details | |
| 8/4/11 |
Q211 | $1.26 | $1.13 | +$0.13 | $87.5M | $79.29M | N/A / N/A | N/A | -22.8% | Details |
